Destiny Schriefer

Also affiliated with Behavioral Pharma (United States)

Pharmacology, Toxicology and PharmaceuticsBiochemistry, Genetics and Molecular BiologyChemistryMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Therapeutic benefit with caveats?: Analyzing social media data to understand the complexities of kratom use”.

Therapeutic benefit with caveats?: Analyzing social media data to understand the complexities of kratom use

Drug and Alcohol Dependence(2021)10.1016/j.drugalcdep.2021.108879

N/A

0DataRank · unranked

67 citations

Jeffrey M. Rogers, Destiny Schriefer, Oliver Grundmann, Kirsten E. Smith

Longitudinal patterns of momentary stress during outpatient opioid agonist treatment: A growth-mixture-model approach to classifying patients

Drug and Alcohol Dependence(2021)10.1016/j.drugalcdep.2021.108884

N/A

0DataRank · unranked

12 citations

Kirsten E. Smith, Destiny Schriefer, Leigh V. Panlilio, David H. Epstein, Kenzie L. Preston +1 more

Kratom use as more than a “self-treatment”

The American Journal of Drug and Alcohol Abuse(2022)10.1080/00952990.2022.2083967

N/A

0DataRank · unranked

60 citations

Kelly E. Dunn, Jeffrey M. Rogers, Oliver Grundmann, Christopher R. McCurdy, Albert Garcia‐Romeu +4 more

Nonfatal opioid overdoses before and after Covid-19: Regional variation in rates of change

PLoS ONE(2022)10.1371/journal.pone.0263893

N/A

0DataRank · unranked

13 citations

Kirsten E. Smith, Leigh V. Panlilio, Destiny Schriefer, Kenzie L. Preston, Aliese Alter +7 more